Radiographic and micro-computed tomographic imaging of lipopolysaccharide- mediated bone resorption

Annals of Otology, Rhinology and Laryngology

Volumn 118, Issue 5, 2009, Pages 391-396

  Nason, Robert ^a   Lee, Dong H ^a   Jung, Jae Y ^a   Chole, Richard A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Calvaria; Cholesteatoma; Chronic otitis media; Micro computed tomography; Osteoclast; Pseudomonas aeruginosa

Indexed keywords

LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE RADIOGRAPHY; CONTROLLED STUDY; DISEASE MODEL; EXPERIMENTAL MODEL; IN VIVO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 66249083523     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940911800512     Document Type: Article

References (30)

1. Müller J. Über den feineren Bau und die Formen der krankhaften Geschwülste. Berlin: Reimer G, 1838.
2. Cruveilhier LJB. Anatomie pathologique du corpus humani. Paris: JB Balliere, 1829.
3. da Costa SS, Paparella MM, Schachern PA, Yoon TH, Kimberley BP. Temporal bone histopathology in chronically infected ears with intact and perforated tympanic membranes. Laryngoscope 1992;102:1229-1236
4. Alliston T, Derynck R. Medicine: interfering with bone remodelling. Nature 2002;416:686-687 (Pubitemid 34429130)
5. Albino AP, Kimmelman CP, Parisier SC. Cholesteatoma: a molecular and cellular puzzle. Am J Otol 1998;19:7-19.
6. Fliss DM, Shoham I, Leiberman A, Dagan R. Chronic suppurative otitis media without cholesteatoma in children in southern Israel: incidence and risk factors. Pediatr Infect Dis J 1991;10:895-899
7. Nakagawa T, Yadohisa O, Komune S, Uemura T. A 16-year survey of changes in bacterial isolates associated with chronic suppurative otitis media. Eur Arch Otorhinolaryngol 1994;251(suppl 1):S27-S32. (Pubitemid 24275968)
8. Henderson B, Nair SP. Hard labour: bacterial infection of the skeleton. Trends Microbiol 2003;11:570-577 (Pubitemid 37500908)
9. Zhuang L, Jung JY, Wang EW, et al. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo. Laryngoscope 2007;117:841-847
10. Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis. J Assoc Res Otolaryngol (in press).
11. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004;4:499-511. (Pubitemid 38931765)
12. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088 (Pubitemid 29001265)
13. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007;109:1574-1583 (Pubitemid 46239591)
14. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat Immunol 2002;3:354-359 (Pubitemid 34308623)
15. Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 2004;53:735-740
16. Wooten RM, Ma Y, Yoder RA, et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002;168:348-355
17. Adachi O, Kawai T, Takeda K, et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998;9:143-150 (Pubitemid 28361303)
18. Rasband WS. ImageJ. Bethesda, Md: US National Institutes of Health, 1997-2007.
19. Stock SR, Ignatiev KI, Foster SA, Forman LA, Stern PH. MicroCT quantification of in vitro bone resorption of neonatal murine calvaria exposed to IL-1 or PTH. J Struct Biol 2004;147:185-997
20. Zou W, Bar-Shavit Z. Dual modulation of osteoclast differentiation bv lipopolysaccharide. J Bone Miner Res 2002;17:1211-1218 (Pubitemid 34680497)
21. Peek FA, Huisman MA, Berckmans RJ, Sturk A, Van Loon J, Grote JJ. Lipopolysaccharide concentration and bone resorption in cholesteatoma. Otol Neurotol 2003;24:709-713 (Pubitemid 37122532)
22. Aznar C, Fitting C, Cavaillon JM. Lipopolysaccharide-induced production of cytokines by bone marrow-derived macrophages: dissociation between intracellular interleukin 1 productionand interleukin 1 release. Cytokine 1990;2:259-265
23. Alexander C, Rietschel ET. Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 2001;7:167-202. (Pubitemid 32894573)
24. West AP, Koblansky AA, Ghosh S. Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 2006;22:409-437
25. Itoh K, Udagawa N, Kobayashi K, et al. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J Immunol 2003;170:3688-3695 (Pubitemid 36359239)
26. Takami M, Kim N, Rho J, Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. J Immunol 2002;169:1516-1523
27. Kirikae T, Nitta T, Kirikae F, et al. Lipopolysaccharides (LPS) of oral black-pigmented bacteria induce tumor necrosis factor production by LPS-refractory C3H/HeJ macrophages in a way different from that of Salmonella LPS. Infect Immun 1999;67:1736-1742 (Pubitemid 29144391)
28. Smith MF Jr, Mitchell A, Li G, et al. Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 2003;278:32552-32560
29. Coats SR, Reife RA, Bainbridge BW, Pham TT, Darveau RP. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect Immun 2003;71:6799-6807
30. Chiang CY, Kyritsis G, Graves DT, Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 1999;67:4231-4236 (Pubitemid 29357050)